| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/30/1998 | EP0866859A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 09/30/1998 | EP0866857A1 E6 binding proteins |
| 09/30/1998 | EP0866852A1 Tissue-specific and target rna-specific ribozymes |
| 09/30/1998 | EP0866851A1 Tumour vaccine and process for the preparation thereof |
| 09/30/1998 | EP0866806A1 Method of mobilizing hematopoietic stem cells |
| 09/30/1998 | EP0866805A1 PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
| 09/30/1998 | EP0866804A2 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 09/30/1998 | EP0866801A1 Cyclopeptolides |
| 09/30/1998 | EP0866800A2 Antineoplastic peptides |
| 09/30/1998 | EP0866799A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 09/30/1998 | EP0866797A1 Glycine and phaseolus alpha-d-galactosidases |
| 09/30/1998 | EP0866726A1 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 09/30/1998 | EP0866721A1 Targeted adenovirus vectors |
| 09/30/1998 | EP0866720A1 Methods of increasing lean tissue mass using ob protein compositions |
| 09/30/1998 | EP0866719A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/30/1998 | EP0866718A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 09/30/1998 | EP0866717A1 Oligodendrocyte-specific protein and method for treating disease |
| 09/30/1998 | EP0866716A1 Methods of treating disorders of non-visual sensory epithelia |
| 09/30/1998 | EP0866711A1 Method of inhibiting sleep apnea |
| 09/30/1998 | EP0866704A1 Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 09/30/1998 | EP0866701A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound |
| 09/30/1998 | EP0866695A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 09/30/1998 | EP0866690A1 Endoparasiticidal agents |
| 09/30/1998 | EP0866683A1 Composition and method for treating diseased nails |
| 09/30/1998 | EP0866654A1 Method for treating hepatitis virus infection |
| 09/30/1998 | EP0781092A4 Method of sensitizing tumor cells with adenovirus e1a |
| 09/30/1998 | EP0643769B1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II |
| 09/30/1998 | EP0627929B1 Inhibitors of thrombosis |
| 09/30/1998 | EP0621873B1 A novel human kunitz-type protease inhibitor and variants thereof |
| 09/30/1998 | EP0526544B1 Therapeutic uses of actin-binding compounds |
| 09/30/1998 | CN1194651A Modified/chimeric superantigens and their use |
| 09/30/1998 | CN1194308A Method for producing recombined human liver cytokinin and its use for curing serious hepatic disease |
| 09/30/1998 | CN1040003C Process for preparing trifluoromethylktone derivatives |
| 09/29/1998 | US5814716 Cell lines from a transgenic mouse which express biologically active IX factor |
| 09/29/1998 | US5814667 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 09/29/1998 | US5814640 Method of treating gastrointestinal malignancies |
| 09/29/1998 | US5814620 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 09/29/1998 | US5814619 Treating with antiproliferative agents, antitumor agents |
| 09/29/1998 | US5814611 Pharmaceutical for the therapy of immune deficiency conditions |
| 09/29/1998 | US5814610 Tetrapeptides to hexapeptides with specific amino acid sequences for wound healing agents and osteoblast or fibroblastic growth promoters |
| 09/29/1998 | US5814609 Compositions containing a disintegrin and methods for its use in preventing metastasis and other conditions |
| 09/29/1998 | US5814607 Pulmonary delivery of active fragments of parathyroid hormone |
| 09/29/1998 | US5814605 Therapeutic uses of keratinocyte growth factor |
| 09/29/1998 | US5814604 A pair of polypeptide chains disulfide bonded to form a dimeric species |
| 09/29/1998 | US5814603 Parathyroid hormone peptide with amino acid sequences |
| 09/29/1998 | US5814602 Heparin-binding proteins |
| 09/29/1998 | US5814601 Synthetic blood comprising polyethylene glycol modified hemoglobin and a colloid starch; low viscosity, high oncotic pressure |
| 09/29/1998 | US5814600 Administering insulin and amylin in specified molar ratio |
| 09/29/1998 | US5814519 Lymphocyte cell line that expresses cd8 protein on surface |
| 09/29/1998 | US5814509 Isolated dna having nucleotide sequence encoding amino acid sequence of human-originated prostacyclin synthase |
| 09/29/1998 | US5814500 Delivery construct for antisense nucleic acids and methods of use |
| 09/29/1998 | US5814486 Herpes simplex virus glycoprotein D variants |
| 09/29/1998 | US5814485 Culturing escherichia coli cells transformed with vector comprising sequence encoding interferon polypeptide, culturing in medium with limited concentration of potassium and sodium ions at specified ph |
| 09/29/1998 | US5814484 Yeast cell comprising specified dna molecule producing biologically active polypeptide |
| 09/29/1998 | US5814482 Eukaryotic layered vector initiation systems |
| 09/29/1998 | US5814481 Heat shock-like protein |
| 09/29/1998 | US5814480 Polynucleotide sequence, for detection of the polypeptide in a biological sample |
| 09/29/1998 | US5814478 Isolated nucleotide sequence encoding a polypeptide for treating muscular disorders or nervous system disorders |
| 09/29/1998 | US5814477 Recombinant clostridial toxin protein |
| 09/29/1998 | US5814475 Antibodies and dna for drugs and diagnosis |
| 09/29/1998 | US5814469 Interleukins, cytokines and tumor necrosis factor for cancer diagnosis |
| 09/29/1998 | US5814467 APO AI polypeptides, diagnostic methods and systems for quantifying APO AI, and therapeutic methods |
| 09/29/1998 | US5814464 Nucleic acids encoding TIE-2 ligand-2 |
| 09/29/1998 | US5814459 Phosphospecific transcription factor antibodies |
| 09/29/1998 | US5814457 Amino acid sequences for polypeptides, detection of immune complexes and sampling |
| 09/29/1998 | US5814456 Sperm antigen corresponding to a sperm zone binding protein autoantigenic epitope |
| 09/29/1998 | US5814451 Polynucleotides and genetic engineering by bonding |
| 09/29/1998 | US5814441 HTLV-I and HTLV-II peptide antigens and methods |
| 09/29/1998 | US5814344 Method for delivering bioactive agents into and through the mucosally associated lymphoid tissues and controlling their release |
| 09/29/1998 | US5814342 Produced from a water-in-oil emulsion comprising an inner aqueous phase containing a luteinizing hormone-releasing hormone analog and an oil phase containing a homo- or copolymer of lactic acid |
| 09/29/1998 | US5814328 Preparation of collagen using papain and a reducing agent |
| 09/29/1998 | US5814318 Gene expressing human immunoglobulins by immunizing mouse, specific binding human antigens |
| 09/29/1998 | US5814317 Structural alterations of the EGF receptor gene in human gliomas |
| 09/29/1998 | US5814316 Administering an antibody to reverse choleocystokinin |
| 09/29/1998 | US5814315 Methods for the suppression of neu mediated phenotype in tumors |
| 09/29/1998 | US5814314 Non-glycosylated, recombinant human IL 2 in reduced form |
| 09/29/1998 | US5814308 Administering macrophage stimulating protein to treat disorders caused by radiation chemotherapy, ulcers or autoimmune diseases, for regeneration of intestinal crypt cells |
| 09/29/1998 | US5814307 Synthesis of interleukins for cells |
| 09/29/1998 | US5814298 Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 09/29/1998 | US5814297 Amino acid residues covalently linked to a radioisotope |
| 09/29/1998 | US5814295 Determination of lymph nodes enriched in tumor reactive cells their proliferation and their use in adoptive cellular therapy |
| 09/29/1998 | CA2140127C Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor |
| 09/29/1998 | CA2118032C Therapeutic conjugates of toxins and drugs |
| 09/29/1998 | CA2020474C Antiinflammatory and/or antiallergic composition |
| 09/29/1998 | CA1340063C Production of animal lysozyme c via secretion from pichia pastoris and composition therefor |
| 09/29/1998 | CA1340062C Method of inactivating reproductive filterable pathogens |
| 09/27/1998 | CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10 |
| 09/27/1998 | CA2201274A1 Sense and antisense peptides to treat multiple sclerosis |
| 09/24/1998 | WO1998041656A1 Compositions and method for the early diagnosis of ovarian cancer |
| 09/24/1998 | WO1998041652A2 Dna for detecting changes in chromosome 7 |
| 09/24/1998 | WO1998041641A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 09/24/1998 | WO1998041639A1 Serine/threonine protein kinase |
| 09/24/1998 | WO1998041637A1 Cdna encoding a human atp synthase fo subunit d (asysd)(as amended) |
| 09/24/1998 | WO1998041635A1 Human tumorigenesis associated protein, htap |
| 09/24/1998 | WO1998041634A1 Human growth and differentiation protein |
| 09/24/1998 | WO1998041633A1 Human pancreatitis-associated protein, pap-2 |
| 09/24/1998 | WO1998041632A1 Human tumor suppressor |
| 09/24/1998 | WO1998041631A2 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER |
| 09/24/1998 | WO1998041630A1 Histone-like protein (hlp) |
| 09/24/1998 | WO1998041629A2 Death domain containing receptor 5 |